Key result
Complete pacemaker extraction and IV ceftriaxone resolves a case of Neisseria sicca lead endocarditis.
Why the study?
Pacemaker lead endocarditis caused by Neisseria sicca is a rare and emerging infection with increasing incidence and mortality.
Case Report (n=1)
This is the first reported case of Neisseria sicca-associated pacemaker lead endocarditis, highlighting the importance of transesophageal echocardiography for diagnosis and successful treatment with device extraction and antibiotics.
Successful extraction plus ceftriaxone resolved first-reported Neisseria sicca lead endocarditis; leaves management questions open for larger series.
We report the first known case of Neisseria sicca-associated pacemaker lead endocarditis—a disease whose incidence and mortality are growing. A woman in her 70s with a history of transcatheter aortic valve replacement and pacemaker placement 7 months earlier presented with recurrent fevers. She visited the emergency department several times during the past 2 months for these fevers, and she had been given oral antibiotics for presumed urinary tract infections. Investigations revealed blood cultures growing N. sicca. Although transthoracic echocardiogram was negative, transesophageal echocardiogram showed two vegetations on the right atrial lead which suggested pacemaker lead-associated endocarditis. A complete pacemaker and lead extraction was performed, and the patient recovered completely and was discharged home to complete 6 weeks of intravenous ceftriaxone with plans for follow-up echocardiography. We hope that this case will contribute to the growing body of literature regarding device infections, thus leading to earlier identification and treatment.
No takes yet. Share an insight, caveat, or question.
Locke et al. (2022) conducted a case report in Neisseria sicca-associated pacemaker lead endocarditis (n=1). Complete pacemaker and lead extraction and intravenous ceftriaxone was evaluated on Clinical recovery. Complete pacemaker and lead extraction followed by 6 weeks of intravenous ceftriaxone led to complete recovery in a patient with Neisseria sicca-associated pacemaker lead endocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: